| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.25 | 5e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 7e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.2 | 8e-05 |